Verona, Italy

Marilisa Rinaldi

USPTO Granted Patents = 3 

Average Co-Inventor Count = 10.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
3 patents (USPTO):

Title: Marilisa Rinaldi: Pioneering Innovations in CNS Disorder Treatments

Introduction

Marilisa Rinaldi is an accomplished inventor based in Verona, Italy, with a remarkable portfolio of three patents. Her work is primarily focused on the development of pharmaceutical compounds designed to address central nervous system disorders, marking a significant contribution to the field of medicinal chemistry.

Latest Patents

Among her latest innovations are patents related to quinoline and quinazoline derivatives. These compounds exhibit an affinity for 5HT1-type receptors, which play a crucial role in the treatment of conditions such as depression and anxiety. The disclosed methods in her patents provide a comprehensive framework for the preparation of these compounds, highlighting their potential therapeutic applications in conjunction with other active substances.

Career Highlights

Marilisa Rinaldi is currently affiliated with Glaxo Group Limited, where she leverages her expertise to advance innovative solutions in pharmaceutical development. Her dedication to research and development has not only resulted in impactful patents but also solidified her reputation in the industry.

Collaborations

Throughout her career, Marilisa has collaborated with notable colleagues, including Matteo Biagetti and Alessandro Falchi. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas that lead to the successful development of new compounds.

Conclusion

In conclusion, Marilisa Rinaldi stands out as a visionary inventor in the realm of CNS disorder treatments. Her patented innovations represent a significant stride towards effective therapeutic interventions, showcasing her commitment to improving mental health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…